EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 60 / No 1 (January-March 2025) Radioprotection, 60 1 (2025) 76-83 References
Open Access
Issue
Radioprotection
Volume 60, Number 1, January-March 2025
Page(s) 76 - 83
DOI https://doi.org/10.1051/radiopro/2024041
Published online 14 March 2025
  • Aberle DR, Adams AM, et al. 2011. National lung screening trial research team. reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365: 395–409. [CrossRef] [PubMed] [Google Scholar]
  • Alberg AJ, Brock MV, Samet JM. 2005. Epidemiology of lung cancer: looking to the future. J Clin Oncol 23: 3175–3185. [CrossRef] [PubMed] [Google Scholar]
  • Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. 2007. Computed tomography screening and lung cancer outcomes. JAMA 297: 953–961. [CrossRef] [PubMed] [Google Scholar]
  • Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol. 2012 Sep;138(9):1475-86. doi: 10.1007/s00432-012-1228-9. [Google Scholar]
  • Bertho JM, Habib B. 2023. Radiation protection is an attitude. Radioprotection 58: 77–78. [CrossRef] [EDP Sciences] [Google Scholar]
  • Bianchi F, Nicassio F, Marzi M, Belloni E, Dall’olio V, Bernard L, et al. 2011. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Molec Med 3: 495–503. [CrossRef] [PubMed] [Google Scholar]
  • Bigbee WL, Gopalakrishnan V, Weissfeld JL, Wilson DO, Dacic S, Lokshin AE, et al. 2012. A multiplexed serum biomarkers immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening. J Thorac Oncol 7: 698–708. [CrossRef] [PubMed] [Google Scholar]
  • Bochicchio F, Campos-Venuti G, Piermattei S, Nuccetelli C, Risica S, Tommasino L, et al. 2005. Annual average and seasonal variations of residential radon concentration for all the Italian regions. Radiat Measur 40: 686–694. [CrossRef] [Google Scholar]
  • Blanchon T, Bréchot JM, Grenier PA, Ferretti GR, Lemarié E, Milleron B, et al. Dépiscan Group. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer. 2007 Oct;58(1):50-8. doi: 10.1016/j.lungcan.2007.05.009. [Google Scholar]
  • Bochicchio F, Forastiere F, Farchi S, Quarto M, Axelson O. 2005. Residential radon exposure, diet and lung cancer: a case-control study in a Mediterranean region. Int J Cancer 114: 983–991. [CrossRef] [PubMed] [Google Scholar]
  • Carrola J, et al. 2011. Metabolic signatures of lung cancer in biofluids, NMR-based metabonomics of urine. J Proteome Res 10: 221–230. [CrossRef] [PubMed] [Google Scholar]
  • Chapman CJ, et al. 2012. Early CDT-Lung test: improved clinical utility through additional autoantibody assays. Tumor Biol 33: 1319–1326. [CrossRef] [PubMed] [Google Scholar]
  • Chu GCW, Lazare K, Sullivan F. 2018. Serum and blood based biomarkers for lung cancer screening: a systematic review. BMC Cancer 18 (1): 181. [CrossRef] [PubMed] [Google Scholar]
  • Crispo A, Brennan P, Jockel KH, et al. 2004. The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer 91: 1280–1286. [CrossRef] [PubMed] [Google Scholar]
  • Darby S, Hill D, Auvinen A, et al. 2005. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies BMJ 330 (7485): 223. [Google Scholar]
  • Directive 97/43/Euratom, based on ICRP pubblication 60, 1990 [Google Scholar]
  • Directive 2013 /59/Euratom. [Google Scholar]
  • European Commission, Directorate-General for Environment. Radiological protection principles concerning the natural radioactivity of building materials. Publications Office, Vol. 112, Radiation Protection 2000. [Google Scholar]
  • Epicentro ISS (Italian governmental Health Insitute). Radon − Epidemiological features- Available at: https://www.epicentro.iss.it/radon/epidemiologia#:∼:text=L’Iss%20ha%20stimato%20che,che%20ne%20moltiplica%20gli%20effetti [Google Scholar]
  • IARC. 2013. CancerBase No. 11. Lyon, International Agency for Research on Cancer. [Google Scholar]
  • Gasparri R et al. 2016. Volatile signature for early diagnosis of lung cancer. J Breath Res 10: 016007. [CrossRef] [PubMed] [Google Scholar]
  • Gasparri R, Romano R, Sedda G, Borri A, Petrella F, Galetta D, et al. 2017. Diagnostic biomarkers for lung cancer prevention. J. Breath Res 12(2028): 027111. [Google Scholar]
  • Gharibvand L, Shavlik D, Ghamsary M, et al. 2017. The Association between ambient fine particulate air pollution and lung cancer incidence: results from the AHSMOG-2 study. Environ Health Perspect 125 (3): 378–384. [CrossRef] [PubMed] [Google Scholar]
  • Haznadar M, et al. 2016. Urinary metabolite risk biomarkers of lung cancer: a prospective cohort study, Cancer Epidemiol Biomarkers Prev 25: 978–986. [CrossRef] [PubMed] [Google Scholar]
  • Henschke CI, McCauley DI, Yankelevitz DF, et al. 1999. Early lung cancer action project: overall design and findings from baseline screening. Lancet 354 (9173): 99–105. [CrossRef] [PubMed] [Google Scholar]
  • Henschke CI, Yankelevitz DF, et al. 2006. International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355 (17): 1763–1771. [CrossRef] [PubMed] [Google Scholar]
  • IARC. 1988. Man-Made Mineral Fibres and Radon. Lyon, France. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. IARC; 1988; Volume 43. [Google Scholar]
  • Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, et al. DANTE Study Group. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009 Sep 1;180(5):445-53. doi: 10.1164/rccm.200901-0076OC. [Google Scholar]
  • ICRP. 2007. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP 37 (2–4). [Google Scholar]
  • ICRP. 2017. Occupational Intakes of Radionuclides: Part 3. ICRP Publication 137. Ann ICRP 46 (3/4). [Google Scholar]
  • Italian Law, Legislative Decree of 26 May 2000 no. 187. [Google Scholar]
  • Italian Law, Legislative Decree of 26 May 2000 no. 241 [Google Scholar]
  • Italian Law, Legislative Decree of 9 April 2008 no. 81, Articolo 17. [Google Scholar]
  • Italian Law, Legislative Decree of 31 July 2020 no. 101, Titolo II, Articolo 7, comma 40. [Google Scholar]
  • Italian Law, Legislative Decree of 31 July 2020 no. 101, Titolo II, Articolo 7, comma 40. [Google Scholar]
  • Italian Law Legislative Decree of 31 July 2020 no. 101, Titolo IV, Articolo 11. [Google Scholar]
  • Jett JR, Peek LJ, Fredericks L, Jewell W, Pingleton WW, JFR.R. 2014. Audit of the autoantibody test, EarlyCDT-lung, in 1600 patients: an evaluation of its performance in routine clinical practice. Lung Cancer (Amsterdam, Netherlands) 83 (1): 51–55. [CrossRef] [Google Scholar]
  • Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, et al. 2005. Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology 16: 137–145. [CrossRef] [PubMed] [Google Scholar]
  • Lopes Pegna A, Picozzi G, Falaschi F, Carrozzi L, Falchini M, Carozzi FM, et al. ITALUNG Study Research Group. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol. 2013 Jul;8(7):866-75. doi: 10.1097/JTO.0b013e31828f68d6. [CrossRef] [Google Scholar]
  • Lorenzo-González M, Torres-Durán M, Barbosa-Lorenzo R, Provencio-Pulla M, Barros-Dios JM, Ruano-Ravina A. 2019. Radon exposure: a major cause of lung cancer. Expert Rev Respir Med 13 (9): 839–850. [CrossRef] [PubMed] [Google Scholar]
  • Montani F, Marzi MJ, Dezi F, Dama E, Carletti RM, Bonizzi G, et al. miR-Test: a blood test for lung cancer early detection. J Natl Cancer Inst 107 (6): djv063. [Google Scholar]
  • Park SL, Murphy SE, Wilkens LR, Stram DO, Hecht SS, Le Marchand L. 2017. Association of CYP2A6 activity with lung cancer incidence in smokers: the multiethnic cohort study. Plos ONE 12: e0178435. [CrossRef] [PubMed] [Google Scholar]
  • Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012 May;21(3):308-15. doi: 10.1097/CEJ.0b013e328351e1b6. [CrossRef] [PubMed] [Google Scholar]
  • Patz EF Jr, Pinsky P, Gatsonis C et al. 2014. Overdiagnosis in low-dose computed tomography screening for lungcancer. JAMA Intern Med 174 (2): 269–274. [CrossRef] [PubMed] [Google Scholar]
  • Peled N, Hakim M Jr, Bunn PA, Miller YE, Kennedy TC, Mattei J,et al. 2012. Non invasive breath analysis of pulmonary nodules. J Thorac Oncol 7: 1528–1533. [CrossRef] [PubMed] [Google Scholar]
  • Phillips M, et al. 2008. Detection of lung cancer using weighted difital analysis of breath biomarkers. Clin Chim Acta 393: 76–84. [CrossRef] [PubMed] [Google Scholar]
  • Phillips M, Gleeson K, Hughes JM, Greenberg J, Cataneo RN, Baker L, et al. 1999. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 353: 1930–1933. [CrossRef] [PubMed] [Google Scholar]
  • Raaschou-Nielsen O, Andersen ZJ, Beelen R, et al. 2013. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol 14 (9): 813–822. [CrossRef] [PubMed] [Google Scholar]
  • Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 2012 Apr;67(4):296-301. doi: 10.1136/thoraxjnl-2011-200736. [CrossRef] [PubMed] [Google Scholar]
  • Sozzi G, Boeri M, Rossi M, et al. 2014. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol 32 (8): 768–773. [CrossRef] [PubMed] [Google Scholar]
  • Taylor R, Najafi F, Dobson A. 2007. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int J Epidemiol 36: 1048–1059. [CrossRef] [PubMed] [Google Scholar]
  • UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation). 2009. Effects of Ionising Radiation. UNSCEAR 2006 Report to the General Assembly − Volume II, Annex E: Sources-to-effects assessment for radon in homes and workplaces. New York: United Nations. [Google Scholar]
  • Uso M, Jantus-Lewintre E, Sirera R, Bremnes RM, Camps C. 2014. miRNA detection methods and clinical implications in lung cancer. Future Oncol 10 (14): 2279–2292. [CrossRef] [PubMed] [Google Scholar]
  • van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. de Koning HJ. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009 Dec 3;361(23):2221-9. doi: 10.1056/NEJMoa0906085. [CrossRef] [PubMed] [Google Scholar]
  • Wang C et al. 2015. A five-miRNA paneel identified from a multicentric case-control study serves as a novel diagnostic tool for ethnically diverse non small cell lung cancer patients. EBioMedicine 2: 1377–1385. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • World Health Organization. 2009. WHO Handbook on Indoor Radon: A Public Health Perspective. Geneva, Switzerland: World Health Organization. [Google Scholar]
  • Yokota J, Shiraishi K, Kohno T. 2010. Genetic basis for susceptibility to lung cancer: Recent progress and future directions. Adv Cancer Res 109: 51–72. [CrossRef] [PubMed] [Google Scholar]
  • Zhong L, Goldberg MS, Parent ME, Hanley JA. 2000. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung Cancer 27: 3–18. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.